These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5152029)

  • 1. Daunorubicin metabolism: estimation of daunorubicin reductase.
    Bachur NR; Huffman DH
    Br J Pharmacol; 1971 Dec; 43(4):828-33. PubMed ID: 5152029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions.
    Bachur NR
    J Pharmacol Exp Ther; 1971 Jun; 177(3):573-8. PubMed ID: 5568811
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of daunorubicin by a barbiturate-sensitive aldehyde reductase from rat liver.
    Turner AJ; Hick PE
    Biochem J; 1976 Dec; 159(3):819-22. PubMed ID: 1008838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daunorubicin metabolites in human urine.
    Takanashi S; Bachur NR
    J Pharmacol Exp Ther; 1975 Oct; 195(1):41-9. PubMed ID: 1181403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daunorubicin reductase activity in leukemia leukocyte homogenates.
    Gola A
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):815-8. PubMed ID: 398688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat.
    Cusack BJ; Young SP; Olson RD
    Cancer Chemother Pharmacol; 1995; 35(3):213-8. PubMed ID: 7805179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and metabolism of rubidazone and daunorubicin in mice.
    Baurain R; Deprez-De Campeneere D; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):37-41. PubMed ID: 498418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake and metabolism of daunorubicin as determined by high-performance liquid chromatography. Application to L1210 cells.
    Baurain R; Zenebergh A; Trouet A
    J Chromatogr; 1978 Sep; 157():331-6. PubMed ID: 568150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative metabolism of daunorubicin and 4-demethoxydaunorubicin in mice and rabbits.
    Broggini M; Sommacampagna B; Paolini A; Dolfini E; Donelli MG
    Cancer Treat Rep; 1986 Jun; 70(6):697-702. PubMed ID: 3524823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC determination of daunorubicin and daunorubicinol in human plasma.
    Hulhoven R; Desager JP
    Biomedicine; 1977 Apr; 27(3):102-4. PubMed ID: 890014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat.
    Cusack BJ; Young SP; Vestal RE; Olson RD
    Cancer Chemother Pharmacol; 1997; 39(6):505-12. PubMed ID: 9118462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol.
    Eksborg S
    J Chromatogr; 1978 Feb; 149():225-32. PubMed ID: 649731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicin.
    Aszalos AA; Bachur NR; Hamilton BK; Langlykke AF; Roller PP; Sheikh MY; Sutphin MS; Thomas MC; Wareheim DA; Wright LH
    J Antibiot (Tokyo); 1977 Jan; 30(1):50-8. PubMed ID: 838632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daunorubicin metabolism by rat tissue preparations.
    Bachur NR; Gee M
    J Pharmacol Exp Ther; 1971 Jun; 177(3):567-72. PubMed ID: 4398190
    [No Abstract]   [Full Text] [Related]  

  • 16. Daunorubicin metabolism by human hematological components.
    Huffman DH; Bachur NR
    Cancer Res; 1972 Mar; 32(3):600-5. PubMed ID: 4400822
    [No Abstract]   [Full Text] [Related]  

  • 17. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin.
    Bains OS; Karkling MJ; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2009 May; 37(5):1107-14. PubMed ID: 19204081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary metabolism and urinary excretion of 4-demethoxydaunorubicin as compared to daunorubicin in rats.
    Catapano CV; Guaitani A; Broggini M; Corada M; Bartosek I; Italia C; Donelli MG
    Anticancer Res; 1988; 8(4):725-31. PubMed ID: 3178163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1.
    Hintzpeter J; Hornung J; Ebert B; Martin HJ; Maser E
    Chem Biol Interact; 2015 Jun; 234():162-8. PubMed ID: 25541467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.